AB
DAWN

Amalgamated Bank’s Day One Biopharmaceuticals DAWN Stock Holding History

Amalgamated Bank’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,466
Closed -$23K – 1935
2025
Q4 		$23K Buy
2,466
+684
+38% +$5.71K ﹤0.01% 2049
2025
Q3 		$13K Hold
1,782
– – ﹤0.01% 2333
2025
Q2 		$12K Hold
1,782
– – ﹤0.01% 2348
2025
Q1 		$14K Hold
1,782
– – ﹤0.01% 2211
2024
Q4 		$23K Hold
1,782
– – ﹤0.01% 2064
2024
Q3 		$25K Sell
1,782
-356
-17% -$5.08K ﹤0.01% 2040
2024
Q2 		$29K Hold
2,138
– – ﹤0.01% 1991
2024
Q1 		$35K Sell
2,138
-6,452
-75% -$96.6K ﹤0.01% 1954
2023
Q4 		$125K Sell
8,590
-38
-0.4% -$461 ﹤0.01% 1931
2023
Q3 		$106K Buy
8,628
+2,268
+36% +$29.6K ﹤0.01% 1972
2023
Q2 		$76K Buy
6,360
+3,459
+119% +$45.2K ﹤0.01% 2155
2023
Q1 		$39K Sell
2,901
-676
-19% -$13.2K ﹤0.01% 2400
2022
Q4 		$77K Hold
3,577
– – ﹤0.01% 2242
2022
Q3 		$72K Buy
3,577
+620
+21% +$13.2K ﹤0.01% 2300
2022
Q2 		$53K Sell
2,957
-77
-3% -$795 ﹤0.01% 2445
2022
Q1 		$30K Buy
+3,034
New +$40.1K ﹤0.01% 2677

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Amalgamated Bank's DAWN Position: Q1 2026 in Review

Amalgamated Bank sold out of Day One Biopharmaceuticals (DAWN) in Q1 2026, closing a stake of 2,466 shares — an estimated $23K sold.

Amalgamated Bank first reported a position in DAWN in Q1 2022 and held it in 16 quarters. The position peaked at $125K in Q4 2023. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Amalgamated Bank reported no remaining Day One Biopharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 2,466 Day One Biopharmaceuticals shares in Q1 2026, an estimated $23K.
  • Amalgamated Bank first reported a position in Day One Biopharmaceuticals in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Day One Biopharmaceuticals position peaked at $125K in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.